Le cancer de la prostate conduit à la découverte d’un nouveau rétrovirus infectieux humain

Jean-Luc Darlix; Marc Sitbon

doi:10.1051/medsci/20072389690

Accueil

Tous les numéros

Volume 23 / Numéro 8-9 (Août-Septembre 2007)

Med Sci (Paris), 23 8-9 (2007) 690-691

Références

Accès gratuit

Numéro		Med Sci (Paris) Volume 23, Numéro 8-9, Août-Septembre 2007


Page(s)		690 - 691
Section		Nouvelles
DOI		https://doi.org/10.1051/medsci/20072389690
Publié en ligne		15 août 2007

Huebner RJ, Todaro GJ. Oncogenes of RNA tumor viruses as determinants of cancer. Proc Natl Acad Sci USA 1969; 64 : 1087–94. [Google Scholar]
Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100 : 57–70. [Google Scholar]
Pagano JS, Blaser M, Buendia MA, et al. Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol 2004; 14 : 453–71. [Google Scholar]
Munger K, Howley PM. Human papillomavirus immortalization and transformation functions. Virus Res 2002; 89 : 213–28. [Google Scholar]
Moradpour D, Penin F, Rice CM. Replication of hepatitis C virus. Nat Rev Microbiol 2007; 5 : 453–63. [Google Scholar]
Marriott SJ, Semmes OJ. Impact of HTLV-I Tax on cell cycle progression and the cellular DNA damage repair response. Oncogene 2005; 24 : 5986–95. [Google Scholar]
Thrasher AJ, Hacein-Bey-Abina S, Gaspar HB, et al. Failure of SCID-X1 gene therapy in older patients. Blood 2005; 105 : 4255–7. [Google Scholar]
Darlix JL, Cristofari G, Rau M, et al. Nucleocapsid protein of human immunodeficiency virus as a model protein with chaperoning functions and as a target for antiviral drugs. Adv Pharmacol 2000; 48 : 345–72. [Google Scholar]
Sitbon M, Denesvre C, Dardalhon V, et al. Les rétrovirus leucémogènes murins : pathogènes, gènes et outils génétiques. Virologie 2001; 5 : 265–93. [Google Scholar]
Rosenberg N, Jolicoeur P. Retroviruses. In : Coffin J, Hughes SH, Varmus HE, eds. Cold Spring Harbor, NY : Cold Spring Harbor Laboratory Press, 1997 : 475–585. [Google Scholar]
Urisman A, Molinaro RJ, Fischer N, et al. Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2006; 2 : e25. [Google Scholar]
Dong B, Kim S, Hong S, et al. An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc Natl Acad Sci USA 2007; 104 : 1655–60. [Google Scholar]
Fan H. A new human retrovirus associated with prostate cancer. Proc Natl Acad Sci USA 2007; 104 : 1449–50. [Google Scholar]
Casey G, Neville PJ, Plummer SJ, et al. RNASEL Arg462Gln variant is implicated in up to 13 % of prostate cancer cases. Nat Genet 2002; 32 : 581–3. [Google Scholar]
Thakur CS, Jha BK, Dong B, et al. Small-molecule activators of RNase L with broad-spectrum antiviral activity. Proc Natl Acad Sci USA 2007; 104 : 9585–90. [Google Scholar]
Battini JL, Rasko JE, Miller AD. A human cell-surface receptor for xenotropic and polytropic murine leukemia viruses: possible role in G protein-coupled signal transduction. Proc Natl Acad Sci USA 1999; 96 : 1385–90. [Google Scholar]
Corbin A, Prats AC, Darlix JL, Sitbon M. A nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia viruses. J Virol 1994; 68 : 3857–67. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.

[1] Huebner RJ, Todaro GJ. Oncogenes of RNA tumor viruses as determinants of cancer. Proc Natl Acad Sci USA 1969; 64 : 1087–94. [Google Scholar]

[2] Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100 : 57–70. [Google Scholar]

[3] Pagano JS, Blaser M, Buendia MA, et al. Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol 2004; 14 : 453–71. [Google Scholar]

[4] Munger K, Howley PM. Human papillomavirus immortalization and transformation functions. Virus Res 2002; 89 : 213–28. [Google Scholar]

[5] Moradpour D, Penin F, Rice CM. Replication of hepatitis C virus. Nat Rev Microbiol 2007; 5 : 453–63. [Google Scholar]

[6] Marriott SJ, Semmes OJ. Impact of HTLV-I Tax on cell cycle progression and the cellular DNA damage repair response. Oncogene 2005; 24 : 5986–95. [Google Scholar]

[7] Thrasher AJ, Hacein-Bey-Abina S, Gaspar HB, et al. Failure of SCID-X1 gene therapy in older patients. Blood 2005; 105 : 4255–7. [Google Scholar]

[8] Darlix JL, Cristofari G, Rau M, et al. Nucleocapsid protein of human immunodeficiency virus as a model protein with chaperoning functions and as a target for antiviral drugs. Adv Pharmacol 2000; 48 : 345–72. [Google Scholar]

[9] Sitbon M, Denesvre C, Dardalhon V, et al. Les rétrovirus leucémogènes murins : pathogènes, gènes et outils génétiques. Virologie 2001; 5 : 265–93. [Google Scholar]

[10] Rosenberg N, Jolicoeur P. Retroviruses. In : Coffin J, Hughes SH, Varmus HE, eds. Cold Spring Harbor, NY : Cold Spring Harbor Laboratory Press, 1997 : 475–585. [Google Scholar]

[11] Urisman A, Molinaro RJ, Fischer N, et al. Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2006; 2 : e25. [Google Scholar]

[12] Dong B, Kim S, Hong S, et al. An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc Natl Acad Sci USA 2007; 104 : 1655–60. [Google Scholar]

[13] Fan H. A new human retrovirus associated with prostate cancer. Proc Natl Acad Sci USA 2007; 104 : 1449–50. [Google Scholar]

[14] Casey G, Neville PJ, Plummer SJ, et al. RNASEL Arg462Gln variant is implicated in up to 13 % of prostate cancer cases. Nat Genet 2002; 32 : 581–3. [Google Scholar]

[15] Thakur CS, Jha BK, Dong B, et al. Small-molecule activators of RNase L with broad-spectrum antiviral activity. Proc Natl Acad Sci USA 2007; 104 : 9585–90. [Google Scholar]

[16] Battini JL, Rasko JE, Miller AD. A human cell-surface receptor for xenotropic and polytropic murine leukemia viruses: possible role in G protein-coupled signal transduction. Proc Natl Acad Sci USA 1999; 96 : 1385–90. [Google Scholar]

[17] Corbin A, Prats AC, Darlix JL, Sitbon M. A nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia viruses. J Virol 1994; 68 : 3857–67. [Google Scholar]